Angiotensin II Inhibits Insulin Binding to Endothelial Cells

Angiotensin II Inhibits Insulin Binding to Endothelial Cells

BackgroundInsulin-mediated glucose uptake in insulin target tissues is correlated with interstitial insulin concentration, rather than plasma insulin concentration. Therefore, insulin delivery to the interstitium of target tissues is very important, and the endothelium may also play an important rol...

Full description

Bibliographic Details
Main Authors:	Su-Jin Oh, Won-Chul Ha, Jee-In Lee, Tae-Seo Sohn, Ji-Hyun Kim, Jung-Min Lee, Sang-Ah Chang, Oak-Kee Hong, Hyun-Shik Son
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2011-06-01
Series:	Diabetes & Metabolism Journal
Subjects:	Angiotensin II Angiotensin II receptor blocker Endothelium Insulin resistance Transcapillary insulin transport
Online Access:	http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-243.pdf

Similar Items

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Molecular targeting therapy with angiotensin II receptor blocker for prostatic cancer
by: Hiroji Uemura, et al.
Published: (2011-12-01)

Einfluss des Angiotensin-II-Rezeptorantagonisten Valsartan auf die chronische Nierentransplantat-Insuffizienz der Ratte
by: Brookman-Amissah, Dominic
Published: (2007)

Thrombin Induces Angiotensin II-Mediated Senescence in Atrial Endothelial Cells: Impact on Pro-Remodeling Patterns
by: Hira Hasan, et al.
Published: (2019-10-01)

Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications
by: Miroslav Radenkovic, et al.
Published: (2016-01-01)

ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)

The Impact of Age-Related Dysregulation of the Angiotensin System on Mitochondrial Redox Balance
by: Ramya eVajapey, et al.
Published: (2014-11-01)

Role of endothelium in angiotensin II formation by the rat aorta and mesenteric arterial bed
by: R. Leite, et al.
Published: (1997-05-01)

Hyponatremia Induced by Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers-A Pilot Study
by: S Bhuvaneshwari, et al.
Published: (2018-07-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

Exercise Protects Against Defective Insulin Signaling and Insulin Resistance of Glucose Transport in Skeletal Muscle of Angiotensin II-Infused Rat
by: Juthamard Surapongchai, et al.
Published: (2018-04-01)

Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats
by: Ik Soo Byon, et al.
Published: (2017-06-01)

Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer
by: S R Gilyarevsky, et al.
Published: (2013-03-01)

Advance in Research of Angiotensin II and Its Receptor and Malignant Tumor
by: Lulu SUN, et al.
Published: (2016-09-01)

Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients
by: Yu-Li Lin, et al.
Published: (2019-02-01)

A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients
by: Elena Monfá, et al.
Published: (2016-09-01)

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
by: Eun Seok Kim, et al.
Published: (2013-12-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: V. V. Fomin
Published: (2016-01-01)

Angiotensin II inhibitor facilitates epidermal wound regeneration in diabetic mice
by: Maria eKamber, et al.
Published: (2015-06-01)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
by: Hyun Woo Lee, et al.
Published: (2021-03-01)

Olmesartan in Management of Proteinuria
by: Satyanarayan Routray, et al.
Published: (2018-02-01)

Inhibition of Angiotensin Converting Enzyme Impairs Anti-staphylococcal Immune Function in a Preclinical Model of Implant Infection
by: Rishi Trikha, et al.
Published: (2020-09-01)

A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
by: Siragy H
Published: (2011-05-01)

Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action
by: Hossein Babaei, et al.
Published: (2011-06-01)

Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort
by: Sungji Moon, et al.
Published: (2020-11-01)

Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
by: M. E. Ougaard, et al.
Published: (2018-10-01)

Angiotensin II Modulates Podocyte Glucose Transport
by: Barbara Lewko, et al.
Published: (2018-07-01)

Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis
by: Qiong Ling, et al.
Published: (2018-02-01)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
by: Zhang C, et al.
Published: (2021-02-01)

Losartan improved hippocampal long‐term potentiation impairment induced by repeated LPS injection in rats
by: Mahmoud Hosseini, et al.
Published: (2021-05-01)

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria
by: Feng-Yi Hsu, et al.
Published: (2017-06-01)

Antihypertensive effects of angiotensin-(1-7)
by: M.C. Chappell, et al.
Published: (1998-09-01)

Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth
by: Kunal Bikram Shaha, et al.
Published: (2020-05-01)

Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
by: Ping-Min Chen, et al.
Published: (2014-04-01)

Angiotensin 1-7 receptor and angiotensin ii receptor 2 blockades prevent the increased serum and kidney nitric oxide levels in response to angiotensin ii administration: Gender-related difference
by: Tahereh Safari, et al.
Published: (2013-01-01)

IS IT WORTH TO DISCONTINUE DRUGS BLOCKING THE ACTIVITY OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PERI-OPERATIVE PERIOD?
by: V. V. Lomivorotov, et al.
Published: (2018-07-01)

Relationship between the expression of angiotensin II receptors type 1 and vasoactive regulators in arterial hypertension
by: Anna V. Logatkina, et al.
Published: (2020-11-01)

Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice
by: Yuan Liu, et al.
Published: (2017-10-01)

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
by: Cheng-Maw Ho, et al.
Published: (2018-04-01)